Crossmark

Routine Ankle-Brachial Index (ABI) measurement: a window into atherosclerosis and early left ventricular dysfunction in patients diagnosed with cancer

Crossref DOI link: https://doi.org/10.1186/s40959-024-00262-w

Published Online: 2024-09-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Golan, Netanel

Brzezinski, Rafael Y.

Slieman, Moaad

Khoury, Shafik

Havakuk, Ofer

Topilsky, Yan

Banai, Shmuel

Laufer-Perl, Michal
License Information

Text and Data Mining valid from 2024-09-12

Version of Record valid from 2024-09-12
More Information

Article History

Received: 9 March 2024

Accepted: 29 August 2024

First Online: 12 September 2024

Declarations

:

: The study was approved by the Tel Aviv Sourasky Medical Center.Helsinki Regulatory Ethics Committee (Identifier: TLV-0228–16(. Due to the retrospective.Nature of the trial, the Ethics Committee waved the requirement for consent.

: Not applicable.

Document is current

Any future updates will be listed below